-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Continuously advancing the internationalization strategy (Series 4) | Keyuan Pharmaceutical showcases at Japan International Pharmaceutical Raw Materials Exhibition and the European Cosmetics Ingredients Expo (Netherlands)!
Publish Time:
2025-04-15
To accelerate its global expansion and deepen its outreach into international markets, recently, Keyuan Pharmaceutical (stock code: 301281.SZ) showcased its flagship products and innovative solutions at two prestigious international trade shows—CPhI Japan, the Japan International Pharmaceutical Ingredients Exhibition, and in-cosmetics Global in the Netherlands, Europe's leading event for cosmetic raw materials. Through these platforms, the company highlighted its cutting-edge expertise in both pharmaceutical and cosmetic ingredient fields, further fostering global collaboration and driving the efficient integration of industry resources.
As one of the leading indicators in the global pharmaceutical industry, CPHI annually draws pharmaceutical companies, research institutions, and industry experts from around the world to jointly explore the latest trends and technological innovations shaping the pharmaceutical sector.

Gao Chunpo, Chairman and President of Keyuan Pharmaceutical, led his team in fostering camaraderie and discussing business opportunities with both new and existing customers from around the globe, further strengthening plans for future market expansion and collaborative partnerships. The company drew significant attention from potential clients by showcasing its core products in therapeutic areas such as blood sugar regulation, cardiovascular & cerebrovascular health, and anesthesia, while highlighting its strengths in R&D, manufacturing, and quality control.

Meanwhile, the international cosmetics ingredients exhibition, in-cosmetics Global 2025, was held grandly in the Netherlands. As a leading event in the cosmetics industry, in-cosmetics Global drew together cosmetic ingredient suppliers, manufacturers, and brand owners from around the globe. At the show, Keyuan Pharmaceutical showcased its cutting-edge R&D achievements and product strengths in the field of cosmetic ingredients, forging valuable connections with numerous international clients and laying a solid foundation for the company's expansion into the global cosmetics ingredients market.
|
|
|
|
|
|
In recent years, Keyuan Pharmaceutical has steadily and firmly advanced its internationalization strategy in depth, achieving remarkable results. By tackling international certifications head-on and forging overseas marketing partnerships, the company has gradually established a multi-dimensional global sales network spanning Europe, the Americas, and the Asia-Pacific region. This has continuously strengthened its core competitiveness and enhanced its international influence, with collaborative clients now reaching more than 20 countries and regions worldwide.
This dual exhibition collaboration marks a crucial step for Keyuan Pharmaceutical in executing its global expansion strategy. The company will continue to increase investments in R&D innovation and international outreach, further enhancing its overall strength and market position.
Keyuan Pharmaceutical will take this exhibition as an opportunity to deepen its localized operations, further strengthen cooperation with international clients, and propel China’s high-end, Made-in-China raw materials onto the global stage—ultimately delivering superior pharmaceutical products and services to patients worldwide.
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline



